Clinical Study With Lyrica In Patients Suffering From Epilepsy

Viatris

Status: Completed

Conditions: Epilepsy; Neuralgia

Treatments: Drug: Lyrica (pregabalin)

Study type: Observational

Funder types: Industry

Identifiers

NCT00922987

A0081236

Details and patient eligibility

About

Clinical study with Lyrica (pregabalin) in patients suffering from epilepsy. This drug is used as adjunctive therapy with one or more antiepileptics. Lyrica has potential to reduce seizure frequency.

Full description

• Included all adult patients with partial seizures and without contraindications according to Summary of Product Characteristics (SmPC).

Enrollment: 286 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with partial seizures.

Exclusion criteria

• Contraindications according to Summary of Product Characteristics (SmPC).

Trial design

286 participants in 1 patient group

Lyrica

Description:

Adult patients with partial seizures (type of epilepsy). Inclusion criteria according to Summary of Product Characteristics

Treatment:

Drug: Lyrica (pregabalin)